Pierre is an experienced Healthtech manager and deal maker.

He is the former CEO of Urgo and the former CEO of Fournier Pharma. He transformed Urgo into a global wound care giant, increasing revenue from €30m to €700m through a mix of innovation and accretive M&A. He scaled Fournier’s commercial capabilities in the United States and sold the business to Solvay for €1.3bn (excluding earnouts). Pierre began his career as a finance instructor and Healthtech merchant banker at Paribas.

He is Chairman Emeritus of the Industry Association MedTech in France and is a graduate of HEC Paris.